Exclusive

Publication

Byline

Location

US Patent Issued to The Trustees of the University of Pennsylvania, DANA-FARBER CANCER INSTITUTE on Sept. 8 for "Compounds for the treatment of human immunodeficiency virus" (Pennsylvania, Virginia, Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,194, issued on Sept. 8, was assigned to The Trustees of the University of Pennsylvania (Philadelphia) and DANA-FARBER CANCER INSTITUTE (Bost... Read More


US Patent Issued to HitGen on Sept. 8 for "Immunomodulator" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,195, issued on Sept. 8, was assigned to HitGen Inc. (Chengdu, China). "Immunomodulator" was invented by Jin Li (Chengdu, China), Dengyou Zh... Read More


US Patent Issued to AstraZeneca on Sept. 8 for "N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-quinoline-4-carboxamides" (Swedish Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,196, issued on Sept. 8, was assigned to AstraZeneca AB (Sodertalje, Sweden). "N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-quinoline-4-carbox... Read More


US Patent Issued to NATCO PHARMA on Sept. 8 for "Process for the preparation of venetoclax and its polymorphs thereof" (Indian Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,197, issued on Sept. 8, was assigned to NATCO PHARMA Ltd. (Hyderabad, India). "Process for the preparation of venetoclax and its polymorphs... Read More


US Patent Issued to Shanghai Fosun Pharmaceutical Industrial Development on Sept. 8 for "Amide oxazole compound" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,198, issued on Sept. 8, was assigned to Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. (Shanghai). "Amide oxazole compound" ... Read More


US Patent Issued to The Cleveland Clinic Foundation on Sept. 8 for "Citron kinase inhibitors" (Ohio Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,199, issued on Sept. 8, was assigned to The Cleveland Clinic Foundation (Cleveland). "Citron kinase inhibitors" was invented by Shaun R. St... Read More


US Patent Issued to ASCLETIS PHARMA (CHINA) on Sept. 8 for "GLP-1R agonist and therapeutic method thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,200, issued on Sept. 8, was assigned to ASCLETIS PHARMA (CHINA) Co. Ltd. (Hong Kong). "GLP-1R agonist and therapeutic method thereof" was i... Read More


US Patent Issued to RECURSION PHARMACEUTICALS on Sept. 8 for "MALT-1 modulators" (British, French Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,201, issued on Sept. 8, was assigned to RECURSION PHARMACEUTICALS INC. (Salt Lake City). "MALT-1 modulators" was invented by Peter Ray (Oxf... Read More


US Patent Issued to Novartis on Sept. 8 for "Compounds and compositions as Sppl2a inhibitors" (Swiss, American Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,202, issued on Sept. 8, was assigned to Novartis AG (Basel, Switzerland). "Compounds and compositions as Sppl2a inhibitors" was invented by... Read More


US Patent Issued to BeOne Medicines | on Sept. 8 for "Degradation of Bruton's tyrosine kinase (BTK) by conjugation of BTK inhibitors with E3 ligase ligand methods of use" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,203, issued on Sept. 8, was assigned to BeOne Medicines | GmbH (Basel, Switzerland). "Degradation of Bruton's tyrosine kinase (BTK) by conj... Read More